Human platelet antigen-3 genotype predicts platelet count in patients with HCV infection

In Vivo. 2013 Nov-Dec;27(6):773-7.

Abstract

Background/aim: A low platelet count is one of the most sensitive tests for cirrhosis detection in patients with hepatitis C virus (HCV) infection. We evaluated whether the human platelet antigen (HPA) genotype could predict platelet count in HCV-positive patients.

Materials and methods: We genotyped the HPA 1, 2, 3, 5 and 15 polymorphisms in consecutive patients with HCV infection.

Results: Out of the 56 patients enrolled, 56.1% had liver cirrhosis. The mean platelet count was significantly lower in those with HPA1aa genotype than in those with HPA1ab/bb genotype. Platelet count did not differ among the other HPA polymorphisms. However, at logistic regression analysis, only the HPA3aa genotype and liver cirrhosis were independent predictors of a low platelet count.

Conclusion: HPA3aa is an independent factor for a low platelet count in this cohort of patients with HCV chronic infection regardless of disease stage.

Keywords: HCV; HPA3; Platelet; liver cirrhosis; polymorphism.

MeSH terms

  • Aged
  • Antigens, Human Platelet / genetics*
  • Female
  • Genetic Association Studies
  • Genotype
  • Hepatitis C, Chronic / blood*
  • Hepatitis C, Chronic / genetics
  • Humans
  • Male
  • Middle Aged
  • Platelet Count
  • Polymorphism, Genetic*
  • Sequence Analysis, DNA

Substances

  • Antigens, Human Platelet